Actively Recruiting
Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy
Led by Sun Yat-sen University · Updated on 2021-11-29
50
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Selecting the appropriate surgical approach for congenital cataracts presents challenging for ophthalmologists. This prospective, randomized controlled study aims to compare the prognosis of posterior continuous curvilinear capsulorhexis (PCCC) with or without anterior vitrectomy (A-Vit) in treating congenital cataracts.
CONDITIONS
Official Title
Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with bilateral congenital cataracts without other ocular abnormalities
- Gestational age at birth >37 weeks
- No more than 18 years old
- Pupils could dilate normally pre-operation
- Have signed a consent form
- Can be followed
You will not qualify if you...
- Intraocular pressure >21 mmHg
- History of ocular trauma and intraocular surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
T
Tingfeng Qin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here